BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21343937)

  • 1. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial.
    Szarewski A; Cadman L; Mesher D; Austin J; Ashdown-Barr L; Edwards R; Lyons D; Walker J; Christison J; Frater A; Waller J
    Br J Cancer; 2011 Mar; 104(6):915-20. PubMed ID: 21343937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results: Promising Opportunity for Specific Cancer Education.
    Andersson S; Belkić K; Mints M; Östensson E
    J Cancer Educ; 2021 Feb; 36(1):126-133. PubMed ID: 31522376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Out-reach Colposcopy Clinics and HPV Self-Sampling Decreases Loss to Follow up in a Community based Cervical Cancer Screening Programme.
    Thasneem P; Sudhager A; Nalini C; J SSR; Bharathipriya R; Sridharan V; Balasubramani L
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):419-424. PubMed ID: 38415526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial.
    Arrossi S; Thouyaret L; Herrero R; Campanera A; Magdaleno A; Cuberli M; Barletta P; Laudi R; Orellana L;
    Lancet Glob Health; 2015 Feb; 3(2):e85-94. PubMed ID: 25617202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.
    Fujita M; Nagashima K; Shimazu M; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Hanaoka H; Shozu M; Tsuruoka N; Kasai T; Hata A
    PLoS One; 2023; 18(6):e0286909. PubMed ID: 37289798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial.
    Montealegre JR; Anderson ML; Hilsenbeck SG; Chiao EY; Cantor SB; Parker SL; Daheri M; Bulsara S; Escobar B; Deshmukh AA; Jibaja-Weiss ML; Zare M; Scheurer ME
    Trials; 2020 Oct; 21(1):872. PubMed ID: 33087164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility, Acceptability, and Efficacy of a Community Health Worker-Driven Approach to Screen Hard-to-Reach Periurban Women Using Self-Sampled HPV Detection Test in India.
    Poli UR; Muwonge R; Bhoopal T; Lucas E; Basu P
    JCO Glob Oncol; 2020 Apr; 6():658-666. PubMed ID: 32343627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of scaling-up of HPV self-collection offered by community health workers at home visits to increase screening among socially vulnerable under-screened women in Jujuy Province, Argentina.
    Arrossi S; Paolino M; Thouyaret L; Laudi R; Campanera A
    Implement Sci; 2017 Feb; 12(1):17. PubMed ID: 28193227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a U.S. healthcare system: The STEP trial.
    Winer RL; Lin J; Anderson ML; Tiro JA; Meenan RT; Hansen K; Gao H; Sparks A; Greene DN; Kilgore-Martin S; Green BB; Buist DSM
    Contemp Clin Trials; 2022 Nov; 122():106960. PubMed ID: 36241145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening.
    Costa S; Verberckmoes B; Castle PE; Arbyn M
    Br J Cancer; 2023 Mar; 128(5):805-813. PubMed ID: 36517552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials.
    Di Gennaro G; Licata F; Trovato A; Bianco A
    Front Public Health; 2022; 10():1003461. PubMed ID: 36568753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening.
    Lefeuvre C; De Pauw H; Le Duc Banaszuk AS; Pivert A; Ducancelle A; Rexand-Galais F; Arbyn M
    Int J Public Health; 2022; 67():1604284. PubMed ID: 35283720
    [No Abstract]   [Full Text] [Related]  

  • 13. Perceptions and Experiences of Human Papillomavirus (HPV) Infection and Testing among Low-Income Mexican Women.
    León-Maldonado L; Wentzell E; Brown B; Allen-Leigh B; Torres-Ibarra L; Salmerón J; Billings DL; Thrasher JF; Lazcano-Ponce E
    PLoS One; 2016; 11(5):e0153367. PubMed ID: 27149525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of womens participation in cervical cancer screening trial, Maharashtra, India.
    Nene B; Jayant K; Arrossi S; Shastri S; Budukh A; Hingmire S; Muwonge R; Malvi S; Dinshaw K; Sankaranarayanan R
    Bull World Health Organ; 2007 Apr; 85(4):264-72. PubMed ID: 17546307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sociodemographic characteristics associated with cervical cancer screening participation by send-to-all and opt-in HPV self-sampling: Who benefits? Results from a randomized controlled trial among long-term non-attending women in Norway.
    Hansen BT; Nygård M; Castle PE; Burger EA; Aasbø G
    Int J Cancer; 2024 May; ():. PubMed ID: 38751040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding Cervical Cancer Screening in Mozambique: Challenges Associated With Diagnosing and Treating Cervical Cancer.
    Batman S; Rangeiro R; Monteiro E; Changule D; Daud S; Ribeiro M; Tsambe E; Bila C; Osman N; Carrilho C; Neves A; Atif H; De Jesus C; Mariano A; Moretti-Marques R; Vieira M; Fontes-Cintra G; Lopes A; Batware JC; Luis E; Grover S; Baker E; Fellman B; Montealegre J; Castle PE; Jeronimo J; Chiao E; Lorenzoni C; Schmeler K; Salcedo MP
    JCO Glob Oncol; 2023 Sep; 9():e2300139. PubMed ID: 37824802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct mailing of HPV self-sampling kits to women aged 50-65 non-participating in cervical screening in the Czech Republic.
    Ngo O; Chloupková R; Cibula D; Sláma J; Mandelová L; Hejduk K; Hajdúch M; Minka P; Koudeláková V; Jaworek H; Trnková M; Vaněk P; Dvořák V; Dušek L; Májek O
    Eur J Public Health; 2024 Apr; 34(2):361-367. PubMed ID: 38224266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial.
    Zhang Y; Du H; Wang C; Huang X; Qu X; Wu R
    Infect Agent Cancer; 2024 Apr; 19(1):16. PubMed ID: 38664748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resilience of the Dutch HPV-based cervical screening programme during the COVID-19 pandemic.
    Olthof EMG; Aitken CA; Siebers AG; van Kemenade FJ; de Kok IMCM
    Public Health; 2024 Feb; 227():42-48. PubMed ID: 38103276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the carbon footprint of alternative sampling approaches for cervical screening in the UK: A descriptive study.
    Whittaker M; Davies JC; Sargent A; Sawyer M; Crosbie EJ
    BJOG; 2024 Apr; 131(5):699-708. PubMed ID: 38012840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.